Embryonic production of oestrogen is thought to play an important role in conceptus-maternal signalling during early pregnancy in mares, and may be regulated in an autocrine or paracrine fashion by insulin-like growth factor I (IGF-I). In this study, the hypothesis that IGF-I stimulates embryonic oestrogen synthesis, which in turn stimulates uterine IGF-I secretion was tested. Specific sources of IGF-I in the uterine lumen were characterized. Preimplantation embryos, uterine biopsies, and uterine flush fluids were collected on day 13 of pregnancy. Embryos were cultured whole for 24 h, or dispersed and incubated in serum-free culture medium supplemented with androstenedione or testosterone (0-10 µg ml -1 ) and IGF-I (0-100 ng ml -1 ). Oestrogen synthesis was increased by addition of androgen, but there was no dose-dependent effect of IGF-I. Endometrial explants were cultured for 24, 48 and 72 h in serum-free medium supplemented with oestradiol. IGF-I was measured by radioimmunoassay in embryo-conditioned medium, explant culture medium, blastocoelic fluid, concentrated (؋ 100) uterine flush fluid and endometrial-tissue homogenate. Both the embryo and endometrium produced significant quantities of IGF-I, indicating a role for this growth factor in autocrine-paracrine signalling during early pregnancy. However, secretion of IGF-I by endometrial explants was not modulated by oestrogen.
Introduction
The continuing challenge of embryonic loss during the preimplantation period, and the desire to develop effective in vitro systems for equine embryo culture and manipulation make requisite an increased knowledge of the dynamics of early pregnancy in mares. Current understanding of the first 2 weeks of gestation in domestic animals indicates that the conceptus is an active partner in the successful establishment and maintenance of pregnancy (Roberts et al., 1996) . Signals from the horse conceptus during this period ensure selective transport of viable embryos to the uterus (Freeman et al., 1992) , maintenance of the progesteroneproducing corpus luteum (Sharp et al., 1989) and preparation of a supportive uterine environment. The prodigious production of oestrogen by the trophoblast of the early equine embryo probably plays a role in these processes.
Oestrogen biosynthesis by preimplantation embryos has been documented in a number of species including horses (Flood et al., 1979; Zavy et al., 1979; Goff et al., 1983; Choi et al., 1997; Walters, 1998) , pigs (Perry et al., 1973) , donkeys (Heap et al., 1991) , camels (Skidmore et al., 1994) and llamas (Powell et al., 1999) , and is presumed to participate in critical maternal-conceptus communication.
Results of studies in pigs indicate that conceptus-derived oestrogen may serve as the signal for the maternal recognition of pregnancy (MRP) (Bazer and Thatcher, 1977) , and influence endometrial protein secretion as well as uterine contractility and embryonic spacing (for review, see Roberts et al., 1993; Geisert and Conley, 1998) . In llamas, exogenous oestrogen may support extended luteal function (Powell et al., 1999 ). The precise role of embryonic oestrogen secretion in mares has been difficult to elucidate.
The role of insulin-like growth factor I (IGF-I) as a paracrine-autocrine modulator of steroidogenesis in the pig conceptus was investigated by Hofig et al. (1991) . It has been hypothesized that there is a positive 'feed forward system' by which embryonic oestrogen enhances uterine secretion of IGF-I. In turn, IGF-I of uterine (paracrine) or conceptus (autocrine) origin increases the activity of the oestrogen-synthesizing cytochrome P450 aromatase (P450arom) in the embryo (Simmen et al., 1993 (Simmen et al., , 1995 . Similar tissue-specific expression patterns for P450arom in preimplantation pig (Conley et al., 1994) and equine (Walters et al., 2000) embryos indicates that these species may share common regulatory mechanisms.
The synthesis and secretion of IGF-I by both the embryo and endometrium underscore the importance of this growth factor in early pregnancy. Uterine expression of IGF-I is widely documented (for review, see Simmen et al., 1995) . Expression of the genes for IGF-I and the receptor (IGF-IR) in the preimplantation embryo has been reported for a number of species including cattle (Watson et al.,et al., 1994) . Little is known about IGF-I synthesis or IGF-IR expression by equine embryos.
Oestrogen is known to enhance endometrial secretion of IGF-I in rodents (Murphy et al., 1987; Murphy and Ghahary, 1990) and primates (Adesanya et al., 1996) and it is possible that oestrogen-mediated control of uterine IGF-I represents an important, more universal, paracrine or autocrine signal for support of early pregnancy. Embryonic oestrogen may also increase uterine IGF-I production in mares. IGF-I has been detected in uterine flushes from pregnant mares (Salute and Tucker, 1992) , and may play a role in the control of oestrogen production by the equine conceptus. However, the specific sources, quantities, and regulatory mechanisms of IGF-I secretion have not been well characterized.
The goals of the present study were to test the hypothesis that IGF-I stimulates conceptus oestrogen synthesis at the level of P450arom activity, to identify the sources of IGF-I in the uterine lumen and quantify its secretion, and to determine whether oestrogen stimulates equine endometrial secretion of IGF-I.
Materials and Methods

Embryo collection and tissue biopsy
Cyclic light horse mares (Equus caballus) were teased daily during two breeding seasons. Mares in oestrus were palpated per rectum to monitor ovarian activity. After the detection of a follicle measuring у 30 mm, mares were artificially inseminated on alternate days until ovulation occurred. Ultrasonography was used to confirm pregnancy from 10 days after ovulation onward, and to measure embryo diameter. Blastocyst-stage embryos were collected 13 days after ovulation by transcervical flush (Choi et al., 1997) using 500 ml pre-warmed (37ЊC) sterile PBS. Mares were inseminated on subsequent cycles to allow for multiple embryo collections per mare. Over two seasons, 70 embryos were collected from 18 mares. The total flush volume (500 ml) was used to lavage the uterus twice for more complete recovery of luminal proteins, and immediately frozen (-20ЊC) until it was concentrated and assayed for IGF-I. After uterine flush and embryo recovery, endometrial tissues were collected by biopsy (Kenney, 1978) . Endometrial biopsy tissues were either placed in 1.5 ml PBS and snap-frozen in liquid nitrogen or used immediately in culture experiments. Additional biopsies were collected on day 13 after ovulation from eight mares that were not inseminated so that a comparison could be made of tissue concentrations of IGF-I between pregnant and nonpregnant mares. All tissue samples not used in culture were snap-frozen and stored at -80ЊC until later homogenization and assay. All procedures on animals followed protocols approved by the University of California, Davis Animal Care and Use Committee.
Embryonic cell culture
Freshly collected embryos were rinsed three times in 30 ml Hank's balanced salt solution (HBSS; Gibco, Grand Island, NY). The blastocoelic fluid was collected by rupture of the embryo and frozen (-20ЊC) for later analysis. Collapsed embryos were dissociated by gentle mechanical disruption after addition of 5 ml 0.25% (v/v) trypsin-EDTA solution (Gibco) pre-warmed to 38ЊC. At 10 min, fetal calf serum (FCS; Gibco) was added to 10% (v/v). Cells were centrifuged for 5 min at 300 g, rinsed three times in fresh HBSS, and resuspended in Ham's F12:Dulbecco's modified Eagle's medium (DMEM) (Gibco) culture medium supplemented with 0.1% (w/v) bovine serum albumin (BSA; Fraction V, Gibco), penicillin (100 iu ml -1 ) and streptomycin (100 µg ml -1 ). Cells were plated in standard 24-well culture plates at different cell concentrations and incubated in a humidified atmosphere of 5% CO 2 and 95% air at 38ЊC. Treatments were initiated at the time cells were plated (t = 0 h) and performed in triplicate for each experiment. After culture, cell-conditioned medium was collected and frozen (-20ЊC) for later assay. The number and viability of cells were assessed at each period using a haemocytometer and Trypan blue stain.
Three embryos were used and plated at cell concentrations of 5 ϫ 10 3 to 2 ϫ 10 5 cells per well to establish a standard number of cells per well for future experiments. Culture medium was collected at 24 h and total oestrogen accumulation determined by validated radioimmunoassay as described below. In subsequent culture studies, 5 ϫ 10 4 cells per well was used as a standard cell concentration.
Dose-response studies
The dose-dependent effects of IGF-I, androstenedione, and testosterone on oestrogen production and P450arom activity were investigated by adding different concentrations of IGF-I (Gibco) and steroids to the culture medium immediately before plating the cells. Stock solutions of androstenedione or testosterone (Steraloids, Wilton, NH) were prepared at concentrations of 100 µg ml -1 by dissolving the steroids in 1 ml ethanol, drying under air, and resuspending in culture medium overnight. After sterile filtration through a 0.22 µm filter (Millipore Co., Philadelphia, PA), the stock solutions were used to supplement cell cultures at 0.01, 0.1, 1.0 and 10.0 µg ml -1 . After incubation, culture medium was collected and frozen (-20ЊC) until assay. For the initial studies, ten day 13 blastocyst-stage embryos were used to determine the effect of IGF-I on oestrogen production in a serum-free culture. IGF-I (Gibco) was added to the culture medium (F12:DMEM, 0.1% BSA, antibiotics) at 0-500 ng ml -1 . Cells were plated at 5 ϫ 10 4 per well and incubated for 6, 12, 18 and 24 h. Additional cell cultures were supplemented with 0.0, 0.01, 0.1, 1.0 and 10.0 µg ml -1 androstenedione (n = 4) or testosterone (n = 3) and incubated for 24 h to determine the effect of androgen substrate on oestrogen production. Additional IGF-I dose-response studies (n = 4) were carried out at a saturating dose (1.0 µg ml -1 ) of androstenedione. Cultures were supplemented with IGF-I at 0-100 ng ml -1 and incubated for 24 h.
Whole embryo and endometrial cultures
For the determination of conceptus secretion of IGF-I, three intact day 13 embryos were used. Freshly collected embryos were washed three times in HBSS and cultured for 24 h in 50 ml serum-free medium (F12:DMEM, 0.1% BSA, antibiotics) as described above. Blastocoelic fluid (BF) was collected from an additional nine embryos used for dispersed-cell cultures in previous experiments.
Endometrial explant tissue, recovered by biopsy, was rinsed three times in 30 ml pre-warmed (38ЊC) HBSS, cut into pieces of approximately 2 mm with sterile surgical scissors, and placed in standard 24-well plates (one piece per 2 ml well) in 2 ml Ham's F12:DMEM culture medium supplemented with 0.1% BSA (w/v), penicillin (100 iu ml -1 ) and streptomycin (100 µg ml -1 ). Explants were incubated in a humidified atmosphere of 5% CO 2 and 95% air at 38ЊC for 24, 48 or 72 h. After incubation, culture medium was collected and frozen at -20ЊC until later assay. Explant wet mass was recorded for each treatment well. Cultures were supplemented with oestradiol (Steraloids) from 0 to 10 µg ml -1 and incubated for 24 (n = 3 experiments), 48 (n = 3) and 72 h (n = 1) to test the ability of oestrogen to stimulate IGF-I production by the endometrium. For each experiment, treatments were performed in triplicate. Data from three experiments were averaged for the 24 and 48 h periods.
Oestrogen radioimmunoassay
Oestrogen was measured in samples of ether-extracted medium as described by Pinaud et al. (1991) with a slight modification. Samples were extracted in 2 ml fresh ether, and cell culture medium (F12:DMEM, 0.1% BSA), rather than plasma, was used to prepare assay controls and test extraction efficiency. The antiserum (Niswender number 244), characterized by England et al. (1974) , is highly specific for oestradiol and has 3% crossreactivity to oestrone and oestriol. The crossreactivity to testosterone, progesterone, and androstenedione is < 0.1%. The limit of sensitivity of the assay was 10 pg ml -1 . Intra-and inter-assay coefficients of variation were 4.8 (n = 28) and 15.5% (n = 28), respectively.
Insulin-like growth factor I radioimmunoassay Insulin-like growth factor I was measured in concentrated (ϫ 100) uterine flushings, culture medium, endometrial tissue homogenate, and BF by a validated, heterologous double antibody radioimmunoassay (Jordan, 1995) . Human recombinant IGF-I (Gibco) was used to prepare assay standards (0.25-64 ng ml -1 ) and to iodinate IGF-I (Baxter et al., 1982) . Radiolabelled IGF-I ( 125 I-labelled IGF-I) was diluted in assay buffer (0.03 mol Na 2 HPO 4 l -1 , 0.25% (w/v) BSA, 0.01% (w/v) EDTA, 0.02% (w/v) protamine sulfate, 0.02% (w/v) sodium azide, pH 7.5; Sigma, St Louis, MO) to 20 000 d.p.m. per 200 µl. The primary antibody, anti-IGF-I-somatomedin-C rabbit antisera (NIDDK, UB3-189), was diluted 1:3000 in assay buffer. The secondary, precipitating, antibody solution was 0.1% (v/v) normal rabbit serum (NRS) and 1% (v/v) goat anti-rabbit gamma globulin (Antibodies Inc., Davis, CA) in 5% polyethyleneglycol assay buffer. Samples (200 µl) and standards (200 µl) were subjected to acid-ethanol (87.5% ethanol, 12.5% (v/v) 2 mol HCl l -1 ) cryoprecipitation, and subsequently neutralized with 0.855 mol Tris l -1 (5:2 v/v). Neutralized samples and standards were stored at 4ЊC for up to 2 weeks before assay. For radioimmunoassay, 100 µl primary antibody solution was added to 100 µl aliquots of samples and standards in polypropylene centrifuge tubes. After incubation for 1 h at room temperature, 200 µl 125 Ilabelled IGF-I (20 000 d.p.m.) was added to all tubes and allowed to equilibrate for 24 h at 4ЊC. One millilitre of the secondary antibody solution was added and incubated for 1 h at room temperature, and tubes were centrifuged at 2500 g for 35 min to precipitate the bound fraction. Radioactivity in the resultant pellet was counted on an automated gamma counter. The limit of sensitivity was 1.55 ng ml -1 . Intra-and interassay coefficients of variation were 2.74 (n = 4) and 8.86% (n = 4), respectively.
Measurement of IGF-I in uterine flushings, endometrial biopsies, blastocoelic fluid, and whole embryo and endometrial explant cultures Uterine flushings (500 ml) were thawed to 4ЊC and concentrated approximately 100-fold using a Centriprep-3 3000 molecular weight-cut-off filter in an Amicon filtration system (Amicon, Beverly, MA). Samples were stirred gently and continuously during the filtration. All procedures were carried out at 4ЊC. Subsequently, flush fluid concentrates were frozen (-20ЊC) until assay. Insulin-like growth factor I concentrations were measured by radioimmunoassay and multiplied by the sample volume to estimate the total IGF-I in the uterine lumen. Endometrial biopsies were thawed and immediately homogenized for 3 min in 1.5 ml PBS. The homogenate was centrifuged at 2500 g for 2 min, and the supernatant was assayed for IGF-I and total soluble protein (Bio-Rad protein assay; Bio-Rad, Richmond, CA). IGF-I concentrations were recorded as ng IGF-I mg -1 total protein to normalize data between tissues. The BF from nine freshly collected (not cultured) embryos was assayed for IGF-I by radioimmunoassay. The total IGF-I in the blastocoele was estimated by calculation of blastocoele volume (v = 4/3πr 3 ). Secretion of IGF-I by the whole embryo or endometrial explants was determined by assay of IGF-I accumulated in the culture medium. Tissue wet mass was used to normalize endometrial secretion data on a ng mg -1 basis.
Statistical analysis
Data are expressed as mean Ϯ SEM. Statistical analysis was performed using Statistical Analysis Systems (SAS) software (SAS Institute Inc., Cary, NC). The relationship between oestrogen production and number of cells was determined by simple regression. Comparisons of mean oestrogen production at different periods and in doseresponse studies were analysed by two-way analysis of variance (ANOVA), and post-hoc analysis was by paired t tests of least squares. Comparisons of mean IGF-I production in oestrogen dose-response studies were analysed by ANOVA with post-hoc analysis by paired t tests of least squares means. A t test was used to compare the IGF-I content of endometrial tissue from pregnant and non-pregnant mares. Differences were considered significant if P < 0.05.
Results
Cell culture validation
Oestrogen production by dispersed embryonic cells in culture increased with number of cells in a linear fashion (r 2 = 0.88; y = 117.7 + 0.027x). Mean oestrogen production increased during a 24 h incubation from 161 to 5385 pg as the corresponding number of cells increased from 5 ϫ 10 3 to 2 ϫ 10 5 cells per well (Fig. 1) . Mean oestrogen secretion was 0.03 pg per cell per day at all cell concentrations. A standard of 5 ϫ 10 4 cells per well was used in subsequent experiments. The profile of oestrogen accumulation from 0 to 48 h in serum-free culture and the rate of production during 6 or 12 h periods are shown (Fig.  2) . The initial rapid rate of accumulation of 137.6 pg h -1 during the first 6 h period slowed (P < 0.05) to 76.7 pg h -1 during the second period (6-12 h) and reached a plateau by 24 h to 52.9 pg h -1 . Between 24 and 48 h the rate of oestrogen production decreased (P < 0.05) to 19.4 pg h -1 . Cell viability was initially greater than 95%, decreased to 60% by 24 h and was < 50% at 48 h. The rate of oestrogen production per viable cell was not significantly different at 6 and 24 h; thus, a standard culture period of 24 h was chosen to evaluate treatment effects.
Embryonic cell culture: dose-response studies
Preliminary experiments using IGF-I supplementation from 0 to 500 ng ml -1 over 6, 12, 18, and 24 h culture periods revealed no significant dose-dependent effect on basal oestrogen production at any time (data not shown). Supplementation with testosterone from 0 to 10 µg ml -1 over 24 h culture (Fig. 3a) resulted in increased (P < 0.001) oestrogen production to a maximum of 111.0 ng per 5 ϫ 10 4 cells from a basal 3.99 ng per 5 ϫ 10 4 cells. There was no additional increase in oestrogen production from 1 to 10 µg ml -1 testosterone. Similarly, supplementation with 0-10 µg androstenedione ml -1 for 24 h (Fig. 3b) resulted in a maximal oestrogen production of 109.0 ng per 5 ϫ 10 4 cells at 10 µg androstenedione ml -1 , and this was not significantly different from oestrogen production at 1 µg androstenedione ml -1 (107.45 ng per 5 ϫ 10 4 cells). In each case, supplementation with androgen at 1 µg ml -1 resulted in maximal oestrogen production. At an aromatase-saturating dose of 1 µg androstenedione ml -1 , basal oestrogen production was 112 ng per 5 x 10 4 cells per day with no significant dose-dependent effect of supplemental IGF-I from 0 to 100 ng ml -1 (Fig. 4) .
Insulin-like growth factor I in uterine flushings, endometrial biopsy tissue homogenates, blastocoelic fluid, and cultures of whole embryos and endometrial explants Insulin-like growth factor I was detected in all uterine flushes analysed (n = 5) from day 13 pregnant mares. When corrected for volume, the total uterine content of IGF-I was 97.5 Ϯ 11.8 ng. Endometrial tissue concentration of IGF-I was 2.13 Ϯ 0.14 ng mg -1 for pregnant mares (n = 14) and not significantly different from 2.15 Ϯ 0.15 ng mg -1 in non-pregnant mares (n = 8). Blastocoelic content of IGF-I in day 13 embryos was 1.26 Ϯ 0.14 ng (n = 9). Mean secretion of IGF-I by intact embryos (n = 3) in serum-free medium was 0.84 Ϯ 0.2 ng h -1 . Endometrial explant secretion (n = 7) of IGF-I was 10.1 Ϯ 0.9 pg mg -1 h -1 .
Endometrial IGF-I production with and without supplemental oestradiol Endometrial secretion of IGF-I in explant cultures incubated for 24 (n = 3 experiments), 48 (n = 3) and 72 h (n = 1) without oestradiol supplementation is shown (Fig.  5) . The mean IGF-I secretion rate during 24 h culture was 10.33 pg mg -1 h -1 for a total of 0.25 ng mg -1 . Over 48 h, the mean secretion rate was 8.36 pg mg -1 h -1 , totalling 0.40 ng mg -1 . Secretion of IGF-I averaged 11.51 pg mg -1 h -1 during the 72 h culture. In the oestradiol dose-response studies, accumulation of IGF-I at 48 h in the control group was 0.40 Ϯ 0.22 ng mg -1 and was not modulated by supplemental oestradiol at 0-10 µg ml -1 . Similarly, no dosedependent effect was observed during the 24 or 72 h periods (data not shown).
Discussion
This study is the first to describe an in vitro cell culture system for the study of steroidogenesis in the equine embryo, and test definitively the role of IGF-I in the control of oestrogen synthesis. The results demonstrate that IGF-I is of both embryonic and endometrial origin during early pregnancy in mares, but do not support the model of a positive 'feed forward' system between IGF-I and embryonic oestrogen secretion. Exogenous IGF-I did not significantly enhance oestrogen production or P450arom activity in cultured equine embryonic cells (day 13) with or without supplemental androstenedione. Reciprocally, oestrogen had no effect on IGF-I secretion from endometrial explants. Although it is difficult to extrapolate data from in vitro studies directly to the in vivo situation, the present data indicate that the model for maternal-conceptus signalling in mares is different from that proposed for pigs. The lack of a dose-dependent stimulation of oestrogen production by IGF-I in the initial studies may reflect a shortage of substrate IGF-IR or other regulatory factors in the serum-free environment. A saturating dose of androstenedione was provided in subsequent experiments to test more definitively the effect of IGF-I on P450arom activity. The lack of a dose-dependent response under these conditions clearly demonstrates that IGF-I does not stimulate P450arom activity in day 13 equine embryos under these culture conditions. It is possible that the equine conceptus does not express IGF-IR at this stage and is therefore unable to respond to IGF-I stimulation; however, this seems unlikely given the fact that IGF-IR is widely expressed in other mammalian embryos (Simmen et al., 1995) . Results in pigs indicate that IGF-I modulates P450arom activity (Hofig et al., 1991) and expression (Ko et al., 1994; Green et al., 1995) in the preimplantation embryo, but an IGF-I-stimulated increase in oestrogen production from pig conceptus tissues has not been demonstrated in vitro.
The observation that addition of androstenedione or testosterone as substrate for P450arom leads to increased oestrogen production by equine embryonic cells indicates that P450arom is not rate-limiting in the day 13 equine conceptus. This conclusion is supported by immunocytochemical and in situ hybridization data showing high P450arom expression in the trophectoderm at this developmental stage (Walters et al., 2000) . Therefore, the rate of oestrogen production is dictated by the precursor pool from earlier steps in steroidogenesis. The limiting step is not known. If oestrogen biosynthesis is a regulated process in the equine embryo, it is likely to be at an earlier point in the steroidogenic pathway. Evidence from work in the ovary indicates that IGF-I regulates the expression and activity of multiple steroidogenic enzymes (for review, see Hammond et al., 1991) including P450scc (Veldhuis et al., 1986; Magoffin et al., 1990; Magoffin and Weitsmann, 1993a; Urban et al., 1994), 3β-hydroxysteroid dehydrogenase (Magoffin and Weitsman, 1993b; deMoura et al., 1997), and P450c17 (deMoura et al., 1997) in addition to P450arom (Adashi et al., 1985; Erickson et al., 1989) . It is possible that IGF-I influences expression or activity of these enzymes in the equine blastocyst.
Support for the use of this dispersed cell culture protocol for study of embryonic steroidogenesis in horses comes from a number of observations. First, the use of dispersed cells allows for multiple treatments to be applied to one embryo, greatly reducing the error due to individual variation noted by Choi et al. (1997) , and allows for optimal use of a small number of scarce embryos. Second, oestrogen production by cells in this serum-free culture system is comparable to that of whole embryos. Choi et al. (1997) reported that mean oestrogen production by whole day 13.5 embryos was 6.33 fg per cell per 2 h over the first 12 h of culture (10% FCS) compared with 7.30 fg per cell per 2 h over the same time period in dispersed-cell cultures. These results indicate that equine embryonic cells are capable of considerable oestrogen synthesis in the absence of exogenous steroid or lipoprotein, and that they have the capacity for de novo cholesterol synthesis or substantial intracellular lipoprotein stores. Evidence of significant lipid storage and metabolism has been observed in cells of the preimplantation equine embryo (Flood et al., 1982) .
The conclusion that IGF-I in the uterine lumen of pregnant mares is of both endometrial and embryonic origin is supported by these results. Endometrial secretion represents the major source of luminal IGF-I with the potential for a significant contribution coming from the preimplantation embryo. The concentration of IGF-I in uterine flush fluid collected on day 13 of pregnancy (97.5 ng) is in close agreement with results of Salute and Tucker (1992) , who reported a mean of 0.146 ng IGF-I ml -1 in flushes (500 ml) collected on days 12, 14, 16 and 17 (0.146 ϫ 500 ml = 73 ng). Similarly, mean IGF-I in the BF of day 13 embryos (1.21 ng ml -1 ), although somewhat higher, is comparable with values reported (Salute and Tucker, 1992) for the yolk sac fluid content of day 14 and day 17 equine conceptuses (0.21 ng ml -1 and 0.81 ng ml -1 , respectively). Secretion of IGF-I by the intact day 13 embryo (0.84 ng ml -1 ) appears Fig. 5 . Accumulation of insulin-like growth factor I (IGF-I) in serum-free cultures of endometrial explants from pregnant mares. Endometrial biopsies taken at day 13 of pregnancy were minced and cultured in serum-free medium for 24 (n = 3 experiments), 48 (n = 3) and 72 h (n = 1). Mean endometrial secretion of IGF-I was 0.01 ng mg -1 h -1 at each time. Data are expressed as mean Ϯ SEM.
to be higher than that reported for conceptus membranes (Salute and Tucker, 1992) . This result is not surprising as embryonic dispersed-cell cultures under the same culture conditions as intact embryos did not produce detectable amounts of IGF-I at cell concentrations as high as 2 ϫ 10 6 cells per well (K. W. Walters, unpublished) . It is possible that disruption of the embryo significantly reduces the capacity for IGF-I synthesis and secretion, but this is not the case with conceptus oestrogen production. Oestrogen production by dispersed cells in serum-free culture is comparable on a per-cell basis to that of intact embryos. It is possible that embryonic synthesis of IGF-I requires more complex intercellular interactions that are disrupted by collapse or dispersal of the embryo. It is also possible, but unlikely, that IGF-I measured in the whole embryoconditioned medium was of maternal origin and sequestered in the BF. The amount of IGF-I produced by intact embryos during a 24 h culture was considerably higher than that measured in the BF.
The present data indicate that endometrial synthesis of IGF-I is not directly stimulated by conceptus oestrogen during early (day 13) pregnancy in mares. Consistent with this conclusion is the lack of endometrial response in vitro to exogenous oestradiol and the finding of similar tissue concentrations of IGF-I in pregnant and non-pregnant mares. Endometrial responsiveness and hence IGF-I secretion may be influenced by the status of oestrogen receptors. Initial studies in mares showed no difference in oestrogen receptor protein between early pregnancy (day 15) and dioestrus (Tomanelli et al., 1991; . McDowell et al. (1999) reported that endometrial mRNA encoding oestrogen receptor α was significantly lower at day 15 of pregnancy than it was in comparable non-pregnant tissue. The downregulation of oestrogen receptor α may affect the uterine response to oestrogen during early pregnancy in mares. The potential for a conceptus-secreted factor to regulate endometrial oestrogen receptor concentrations in mares is intriguing given the evidence in ruminant species for the downregulation of oestrogen receptor and oxytocin R by conceptus interferon-τ Bazer, 1995, 1996) .
It has been suggested that IGF-I serves as an important autocrine-paracrine signal during early pregnancy to coordinate pregnancy recognition and conceptus development (Simmen et al., 1995) . In pigs, IGF-I may act as a paracrine signal from the uterus to coordinate events associated with MRP. Hofig et al. (1991) demonstrated that IGF-I, but not insulin, stimulates P450arom activity in the day 12 pig conceptus. Green et al. (1995) found that IGF-I stimulated expression of P450arom mRNA in day 12 filamentous conceptuses but inhibited expression in small spherical embryos of the same age. These results indicate a role for IGF-I in the regulation of oestrogen synthesis in pig embryos but also suggest that additional modulatory factors are involved.
In summary, this report provides a serum-free cell culture system for the study of steroid production in the horse conceptus and demonstrates that oestrogen biosynthesis in the preimplantation equine embryo is not regulated by IGF-I at the level of P450arom activity. The results further indicate that IGF-I in the uterine lumen of mares during early pregnancy is of endometrial and conceptus origin, and that secretion is not oestrogen-dependent. The significant production and storage of IGF-I within the blastocoel cavity implies an important role for this growth factor. Additional work is needed to reveal the mechanisms for the control of embryonic steroidogenesis and to clarify the role of IGF-I in autocrine-paracrine signalling for the successful maintenance of pregnancy in mares.
